Diane Warden

Active 2004–2011

32
Papers
19,098
Citations
32
h-index
32
i10-index

Citations

Citations per year for Diane Warden1993: 1 citations1994: 1 citations1995: 1 citations2004: 1 citations2005: 6 citations2006: 82 citations2007: 137 citations2008: 229 citations2009: 264 citations2010: 200 citations2011: 192 citations2012: 199 citations2013: 225 citations2014: 210 citations2015: 234 citations2016: 205 citations2017: 205 citations2018: 205 citations2019: 642 citations2020: 588 citations2021: 546 citations2022: 380 citations2023: 363 citations2024: 483 citations2025: 207 citations2026: 9 citations1996–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,091 citing papers, 30.2% of this breakdownCanada: 519 citing papers, 7.5% of this breakdownChina: 506 citing papers, 7.3% of this breakdownUnited Kingdom: 499 citing papers, 7.2% of this breakdownGermany: 367 citing papers, 5.3% of this breakdownAustralia: 258 citing papers, 3.7% of this breakdownItaly: 235 citing papers, 3.4% of this breakdownNetherlands: 224 citing papers, 3.2% of this breakdownJapan: 179 citing papers, 2.6% of this breakdownFrance: 175 citing papers, 2.5% of this breakdownBrazil: 137 citing papers, 2% of this breakdownSpain: 134 citing papers, 1.9% of this breakdown
0%30.2%Other 23.2%

Fields

  • Medicine45.4%
  • Neuroscience31.7%
  • Psychology13.9%
  • Biochemistry, Genetics and Molecular Biology4.3%
  • Pharmacology, Toxicology and Pharmaceutics1.7%
  • Health Professions0.8%
  • Other2.2%

Topics

  • Treatment of Major Depression17%
  • Tryptophan and brain disorders10.1%
  • Functional Brain Connectivity Studies4.2%
  • Stress Responses and Cortisol4%
  • Mental Health Research Topics3.9%
  • Neurotransmitter Receptor Influence on Behavior3.5%
  • Other57.3%

Coauthors

All papers

Open in search
  1. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

    Authors: , , , , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 5,538

  2. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

    Authors: , , , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 3,878

  3. Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report

    Authors: , , , , , , , , , , , - American Journal of Psychiatry 2008 cited by 931

  4. What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression

    Authors: , , , , , - Psychiatric Services 2009 cited by 660

  5. The STAR*D project results: A comprehensive review of findings

    Authors: , , , , - Current Psychiatry Reports 2007 cited by 731

  6. Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 1,049

  7. Medication Augmentation after the Failure of SSRIs for Depression

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 1,012

  8. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report

    Authors: , , , , , , , - Psychological Medicine 2009 cited by 450

  9. Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication

    Authors: , , , , , , , , , - Journal of Clinical Psychopharmacology 2011 cited by 234

  10. The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures

    Authors: , , , , , , , - European Neuropsychopharmacology 2006 cited by 240

  11. Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

    Authors: , , , , , , , , , , , , , , - American Journal of Psychiatry 2011 cited by 373

  12. Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report

    Authors: , , , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 331

  13. Concise Health Risk Tracking Scale

    Authors: , , , , , , , , , , , - The Journal of Clinical Psychiatry 2011 cited by 160

  14. Concise Associated Symptoms Tracking Scale

    Authors: , , , , , , , , , , - The Journal of Clinical Psychiatry 2011 cited by 78

  15. Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report

    Authors: , , , , , , , , , , , , - American Journal of Psychiatry 2007 cited by 342

  16. A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report

    Authors: , , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 260

  17. Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care

    Authors: , , , , , , , , , , - Neuropsychopharmacology 2007 cited by 153

  18. A Comparison of Lithium and T 3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report

    Authors: , , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 564

  19. Sex differences in response to citalopram: A STAR∗D report

    Authors: , , , , , , , , , - Journal of Psychiatric Research 2008 cited by 191

  20. Factors Associated With Health-Related Quality of Life Among Outpatients With Major Depressive Disorder

    Authors: , , , , , , , , , , , - The Journal of Clinical Psychiatry 2006 cited by 160

  21. Presenting characteristics of depressed outpatients as a function of recurrence: Preliminary findings from the STAR*D clinical trial

    Authors: , , , , , , , , , , , - Journal of Psychiatric Research 2005 cited by 121

  22. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

    Authors: , , , , , , , , , - Drug and Alcohol Dependence 2009 cited by 84

  23. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features

    Authors: , , , , , , , , , , , - Journal of Affective Disorders 2005 cited by 260

  24. Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report

    Authors: , , , , , , , , , , - American Journal of Psychiatry 2009 cited by 225